NCT01487200View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

FX006 10 mg

single 3 mL IA injection

DRUG

FX006 40 mg

single 3 mL IA injection

DRUG

FX006 60 mg

single 3 mL IA injection

DRUG

TCA IR 40

single 1 mL IA injection

Trial Locations (2)

5000

Adelaide

Unknown

Perth

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY